Results 291 to 300 of about 36,199 (325)

Pharmacogenetics and pharmacoepidemiology

Pharmacoepidemiology and Drug Safety, 2001
AbstractThis paper seeks to stimulate consideration of the short‐ and long‐term possibilities raised by research into pharmacogenetics and pharmacoepidemiology, to identify potential tissue databanks linked to population data, and to summarize our ethical responsibilities.
openaire   +3 more sources

Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment

Pharmacoepidemiology and Drug Safety
Our objective is to describe how the U.S. Food and Drug Administration (FDA)'s Sentinel System implements best practices to ensure trust in drug safety studies using real‐world data from disparate sources.
Ashish Rai, J. Maro, Sarah Dutcher, Patricia Bright, S. Toh   +4 more
semanticscholar   +1 more source

Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry

Pharmacoepidemiology and Drug Safety
The first paper to specify the core content of pharmacoepidemiology as a profession was published by an ISPE (International Society for Pharmacoepidemiology) workgroup in 2012 (Jones JK et al. PDS 2012; 21[7]:677–689).
V. Osborne, A. Goodin, Joshua Brown, A. Winterstein, Andrew Bate, Catherine Cohet, Lisa Pont, David Moeny, Olaf H. Klungel, Simone Pinheiro, John D Seeger, K. Arnold Chan, Stanley Edlavitch, Hugh Tilson, Deborah Layton   +14 more
semanticscholar   +1 more source

Clinical variables in pharmacoepidemiology

Journal of Psychiatric Research, 1993
Pharmacoepidemiology traditionally concerns itself with the rates at which drugs are prescribed and used in the general population. Interpretations of these data frequently assume that the rates--for psychotropic drugs--reflect primarily the reinforcing properties of the drugs.
Glen D. Mellinger, Mitchell B. Balter, Eberhard H. Uhlenhuth   +2 more
openaire   +2 more sources

Using Taiwan's National Health Insurance research database for pharmacoepidemiology research

, 2020
In order to (1) present the structure of Taiwan’s National Health Insurance (NHI) research databases, along with the comparison with automated databases in other countries, (2) estimate the strengths and weaknesses of the NHI research databases, and (3 ...
F. Hsiao, C. Yang, Yu-Tung A Huang, Weng‐Foung Huang   +3 more
semanticscholar   +1 more source

Pharmacoepidemiology: The Future

Drug Intelligence & Clinical Pharmacy, 1988
Like all other futures, the future of pharmacoepidemiology is not entirely clear. Major forces exist that are driving the agenda for pharmacoepidemiology. This article reviews and weighs these factors and the roles of the major related actors.
openaire   +3 more sources

Time‐related biases in pharmacoepidemiology

Pharmacoepidemiology and Drug Safety, 2020
Observational studies using computerized healthcare databases have become popular to investigate the potential effectiveness of old drugs for new indications. Many of these studies reporting remarkable effectiveness were shown to be affected by different
S. Suissa, S. Dell'aniello
semanticscholar   +1 more source

Pharmacoepidemiology I: A Review of Pharmacoepidemiologic Study Designs

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
This article is the first of two parts on pharmacoepidemiology, a relatively new science that explores drug efficacy or toxicity using large observational study designs. The number of pharmacoepidemiologic studies published in medical journals has increased, as these studies have explored drug‐related questions that at times cannot be answered in ...
Mahyar Etminan, Mahyar Etminan, Ali Samii   +2 more
openaire   +3 more sources

The Promise Of Pharmacoepidemiology

Annual Review of Pharmacology and Toxicology, 1987
Since the 1930s a series of tragic adverse drug reactions (ADRs) has placed progressively more attention on the new field of pharmacoepidemiology. The stimulus for the 1938 Food and Drug Act was thc marketing of elixir of sulfanilamide dissolved in diethylene glycol, which resulted in the death of over 100 children.
openaire   +3 more sources

Pharmacoepidemiology of Diabetes

2007
Type 1 diabetes requires insulin treatment soon after diagnosis and thereafter insulin must be continued life-long without interruption. By some definitions type 1 diabetes may have shorter or longer periods early in the disease during which insulin is not yet needed. Insulin secretagogues are often used in such cases before the diagnosis becomes clear,
J., Rungby, Krentz, A
openaire   +3 more sources